Citation Tools

Download PDFPDF

633 A Phase 1a/1b, dose-escalation/dose-expansion study of NPX267 in subjects with solid tumors known to express HHLA2

Download to a citation manager

Cite this article as:
Naing A, Rivera IR, Johnson M, et al
633 A Phase 1a/1b, dose-escalation/dose-expansion study of NPX267 in subjects with solid tumors known to express HHLA2